Yu Dong

Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer

Yumi Wanifuchi‐Endo, Hiroko Yamashita, Satoru Takahashi et al. · BMC Cancer · 2014 · 59 citations · Full text

Medicine, Molecular Biology, Oncology +17

Single nucleotide polymorphism-based microarray analysis for the diagnosis of hydatidiform moles

Yingjun Xie, Xiaojuan Pei, Yu Dong et al. · Molecular Medicine Reports · 2016 · 16 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Low RAI2 expression is a marker of poor prognosis in breast cancer

Sayaka Nishikawa, Yasuaki Uemoto, Tae‐Sun Kim et al. · Breast Cancer Research and Treatment · 2021 · 15 citations

Medicine, Cancer Biology, Oncology +11

p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma

Wan-Juan Song, Yu Dong, Cheng Luo et al. · Pathology - Research and Practice · 2017 · 13 citations

Medicine, Cancer Biology, Oncology +11

A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

Makoto Kawaguchi, Noboru Hara, Vladimir Bilim et al. · BMC Cancer · 2016 · 12 citations · Full text

Medicine, Oncology, Urology +15